Article

The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.

Department of Nuclear Medicine and PET Research, VU University Medical Center, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.
European Journal of Cardio-Thoracic Surgery (Impact Factor: 2.81). 02/2006; 29(1):26-9. DOI: 10.1016/j.ejcts.2005.10.002
Source: PubMed

ABSTRACT Positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) seems to be superior to computed tomography (CT) in staging the mediastinum in patients with non-small-cell lung cancer (NSCLC). However, recent results suggest that FDG-PET performance characteristics are conditional for nodal size as shown by CT: FDG-PET is more sensitive but less specific with lymph node enlargement on CT. The association between size and the probability of malignancy needs to be known to predict the post-test probabilities after PET, and finally, stratify patients for mediastinoscopy or thoracotomy depending on the PET and CT results. Therefore, we performed a meta-analysis of available studies reporting on the prevalence of metastatic involvement for different size categories of enlarged lymph nodes in patients with NSCLC and were able to include 14 studies. The prevalence of metastatic involvement and conditional test performance of CT and FDG-PET were calculated for lymph nodes measuring 10-15 mm, 16-20 mm and >20 mm. We found a post-test probability for N2 disease of 5% for lymph nodes measuring 10-15 mm on CT in patients with a negative FDG-PET result, suggesting that these patients should be planned for thoracotomy because the yield of mediastinoscopy will be extremely low. For patients with lymph nodes measuring > or =16 mm on CT and a negative FDG-PET result a post-test probability for N2 disease of 21% was found, suggesting that these patients should be planned for mediastinoscopy prior to possible thoracotomy to prevent too many unnecessary thoracotomies in this subset.

0 Bookmarks
 · 
123 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: To evaluate the efficacy of (18)F-FDG PET/CT in depicting metastatic mediastinal lymph nodes in patients with lung squamous-cell carcinoma (LSCC) or lung adenocarcinoma (LAC) in a tuberculosis-endemic country. This study retrospectively reviewed patients with LSCC or LAC, who underwent preoperative (18)F-FDG PET/CT to assess mediastinal lymph node metastasis. Patients with the short-axis of mediastinal lymph node≤15mm were included. PET/CT interpretation was analyzed in two ways. Firstly, with CT for anatomical localization, lymph nodes showing greater (18)F-FDG uptake than vessel pool on PET were regarded malignant. Secondly, lymph nodes with positive uptake on PET were considered malignant, only when nodes had neither calcification nor higher attenuation than vessel pool on CT. One hundred and sixteen LSCCs and 234 LACs were evaluated. With CT for anatomical localization, the sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) of PET were 78.6%, 45.5%, 53.4%, 31.4% and 87.0% in LSCC group, and 61.8%, 66.3%, 65.0%, 42.9% and 80.9% in LAC group. PET showed higher specificity and accuracy in LAC group compared with LSCC group (p=0.001 and p=0.038, respectively). Considering calcification or high attenuation on CT, the sensitivity, specificity, accuracy, PPV and NPV of PET/CT were 71.4%, 67.0%, 68.1%, 40.8% and 88.1% in LSCC group, and 54.4%, 86.1%, 76.9%, 61.7% and 82.2% in LAC group. Compared with PET, PET/CT possessed higher specificity and accuracy in LSCC group (p=0.000 and p=0.000, respectively), and higher specificity, accuracy and PPV in LAC group (p=0.000, p=0.000 and p=0.022, respectively). (18)F-FDG PET displays limited efficacy in assessing mediastinal lymph node metastasis with the short-axis diameter <15mm in LSCC and LAC groups and higher false-positivity in LSCC group. The specificity and accuracy in LSCC and LAC groups are enhanced by interpreting attenuation characteristic on CT.
    Lung cancer (Amsterdam, Netherlands) 04/2014; · 3.14 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: N staging is a key factor when considering the choice of treatment for non-small-lung cancer. It is possible that there is a correlation between N2 metastasis and some risk factors. The objective of the present study was to evaluate associations between several risk factors and N2 metastasis using univariate and multivariate analyses, which may assist clinicians in therapeutic planning. The enrolled patients were divided into two groups on the basis of histopathological results after surgery: those with pN2 disease (N2 group) and those without (N2 group). Sex, age, location, size, maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose PET, histopathological type, and tumor cell grade were compared between N2 and N2 groups. Correlations between each significant factor and groups were analyzed using univariate analyses. Independent risk factors were finally identified with multivariate analyses. A total of 258 patients met the inclusion criteria. Univariate analyses showed significant correlation between size, SUVmax, tumor cell grade, and N2 status (P<0.05). Multivariate logistic regression showed that both SUVmax and tumor cell grade were independent risk factors and had predictive value for N2 disease (P<0.05). There were no N2 node metastases when tumor SUVmax was up to 2.5 and the tumor cell grade was low. However, the likelihood of metastasis increased to 0.29 and 0.28 when tumor SUVmax was greater than 7.5 and when the tumor cell grade was high. SUVmax and tumor cell grade are independent risk factors for N2 metastasis.
    Nuclear Medicine Communications 04/2014; · 1.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The last decade has seen substantial progress in the diagnostic and therapeutic approach to lung cancer, thus meaning that its prognosis has improved. The Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology have therefore produced a national consensus statement to make recommendations for radiological diagnosis and assessment of treatment response in patients with lung cancer. This expert group recommends multi-detector computed tomography as the technique of choice for investigating this disease. The radiology report should include a full assessment by the TNM staging system. Lastly, when the patient is on immunotherapy, response evaluation should employ not only response evaluation criteria in solid tumours, but also immune-related response criteria.
    Clinical and Translational Oncology 11/2014; · 1.60 Impact Factor

Full-text (2 Sources)

Download
82 Downloads
Available from
May 22, 2014